Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Wexler

Showing results (231-240 of 418) with videos related to

Pageof 42
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Preparation of meta-amidino-N,N-disubstituted anilines as potent inhibitors of coagulation factor XaJ M Fevig, J Cacciola, R S Alexander, et al.
Burns : Journal of the International Society for Burn Injuries|June 1, 1994
Terrorist bombing with a 'Molotov cocktail' inside travelling cars: an old weapon for a new burn syndrome?P Benmeir, S Lusthaus, R Talisman, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
SAX-7/L1CAM acts with the adherens junction proteins MAGI-1, HMR-1/Cadherin, and AFD-1/Afadin to promote glial-mediated dendrite extensionElizabeth R Cebul, Arthur Marivin, Leland R Wexler, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
The de novo design and synthesis of cyclic urea inhibitors of factor Xa: initial SAR studiesR A Galemmo, T P Maduskuie, C Dominguez, et al.
Journal of Medicinal Chemistry|December 10, 1993
A novel series of selective, non-peptide inhibitors of angiotensin II binding to the AT2 siteM K VanAtten, C L Ensinger, A T Chiu, et al.
BMJ Open|February 25, 2016
Incidence of adult Huntington's disease in the UK: a UK-based primary care study and a systematic reviewNancy S Wexler, Laura Collett, Alice R Wexler, et al.
Journal of Human Hypertension|November 1, 1995
Discovery of losartan, the first angiotensin II receptor antagonistP B Timmermans, J V Duncia, D J Carini, et al.
European Journal of Pharmacology|August 1, 1994
EXP597, a nonpeptide angiotensin II receptor antagonist with high affinities for the angiotensin AT1 and AT2 receptor subtypesP C Wong, J V Duncia, J B Santella, et al.
Transplantation|August 1, 1985
Tolerance to donor-type skin in the recipient of a bone marrow allograft. Treatment of skin ulcers in chronic graft-versus-host disease with skin grafts from the bone marrow donorH Y Knobler, U Sagher, I J Peled, et al.
Journal of Thrombosis and Thrombolysis|October 12, 2021
Discussion of talks from the symposium: Factor X: From thrombokinase to oral anti-coagulants and beyondLeonard M Milstone, Craig Jackson, Richard C Becker, et al.
Pageof 42

Showing results (231-240 of 418) with videos related to

Sort By:
Pageof 42
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Preparation of meta-amidino-N,N-disubstituted anilines as potent inhibitors of coagulation factor XaJ M Fevig, J Cacciola, R S Alexander, et al.
Burns : Journal of the International Society for Burn Injuries|June 1, 1994
Terrorist bombing with a 'Molotov cocktail' inside travelling cars: an old weapon for a new burn syndrome?P Benmeir, S Lusthaus, R Talisman, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
SAX-7/L1CAM acts with the adherens junction proteins MAGI-1, HMR-1/Cadherin, and AFD-1/Afadin to promote glial-mediated dendrite extensionElizabeth R Cebul, Arthur Marivin, Leland R Wexler, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
The de novo design and synthesis of cyclic urea inhibitors of factor Xa: initial SAR studiesR A Galemmo, T P Maduskuie, C Dominguez, et al.
Journal of Medicinal Chemistry|December 10, 1993
A novel series of selective, non-peptide inhibitors of angiotensin II binding to the AT2 siteM K VanAtten, C L Ensinger, A T Chiu, et al.
BMJ Open|February 25, 2016
Incidence of adult Huntington's disease in the UK: a UK-based primary care study and a systematic reviewNancy S Wexler, Laura Collett, Alice R Wexler, et al.
Journal of Human Hypertension|November 1, 1995
Discovery of losartan, the first angiotensin II receptor antagonistP B Timmermans, J V Duncia, D J Carini, et al.
European Journal of Pharmacology|August 1, 1994
EXP597, a nonpeptide angiotensin II receptor antagonist with high affinities for the angiotensin AT1 and AT2 receptor subtypesP C Wong, J V Duncia, J B Santella, et al.
Transplantation|August 1, 1985
Tolerance to donor-type skin in the recipient of a bone marrow allograft. Treatment of skin ulcers in chronic graft-versus-host disease with skin grafts from the bone marrow donorH Y Knobler, U Sagher, I J Peled, et al.
Journal of Thrombosis and Thrombolysis|October 12, 2021
Discussion of talks from the symposium: Factor X: From thrombokinase to oral anti-coagulants and beyondLeonard M Milstone, Craig Jackson, Richard C Becker, et al.
Pageof 42